Structural and functional insights into the bona fide catalytic state of Streptococcus pyogenes Cas9 HNH nuclease domain

  1. Zhicheng Zuo
  2. Ashwini Zolekar
  3. Kesavan Babu
  4. Victor JT Lin
  5. Hamed S Hayatshahi
  6. Rakhi Rajan
  7. Yu-Chieh Wang  Is a corresponding author
  8. Jin Liu  Is a corresponding author
  1. Shanghai University of Engineering Science, China
  2. University of North Texas Health Science Center, United States
  3. University of Oklahoma, United States

Abstract

The CRISPR-associated endonuclease Cas9 from Streptococcus pyogenes (SpyCas9), along with a programmable single-guide RNA (sgRNA), has been exploited as a significant genome-editing tool. Despite the recent advances in determining the SpyCas9 structures and DNA cleavage mechanism, the cleavage-competent conformation of the catalytic HNH nuclease domain of SpyCas9 remains largely elusive and debatable. By integrating computational and experimental approaches, we unveiled and validated the activated Cas9-sgRNA-DNA ternary complex in which the HNH domain is neatly poised for cleaving the target DNA strand. In this catalysis model, the HNH employs the catalytic triad of D839-H840-N863 for cleavage catalysis, rather than previously implicated D839-H840-D861, D839-H840-N854, D837-D839-H840, or D839-H840-D861-N863. Our study contributes critical information to defining the catalytic conformation of the HNH domain and advances the knowledge about the conformational activation underlying Cas9-mediated DNA cleavage.

Data availability

The data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1 and 2.

Article and author information

Author details

  1. Zhicheng Zuo

    College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Ashwini Zolekar

    Department of Pharmaceutical Sciences, University of North Texas Health Science Center, Fort Worth, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Kesavan Babu

    Department of Chemistry and Biochemistry, University of Oklahoma, Norman, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Victor JT Lin

    Department of Pharmaceutical Sciences, University of North Texas Health Science Center, Fort Worth, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Hamed S Hayatshahi

    Department of Pharmaceutical Sciences, University of North Texas Health Science Center, Fort Worth, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8639-7130
  6. Rakhi Rajan

    Department of Chemistry and Biochemistry, University of Oklahoma, Norman, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Yu-Chieh Wang

    Department of Pharmaceutical Sciences, University of North Texas Health Science Center, Fort Worth, United States
    For correspondence
    yu-chieh.wang@unthsc.edu
    Competing interests
    The authors declare that no competing interests exist.
  8. Jin Liu

    Department of Pharmaceutical Sciences, University of North Texas Health Science Center, Fort Worth, United States
    For correspondence
    jin.liu@unthsc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1067-4063

Funding

Shanghai Municipal Education Commission (Program for Professor of Special Appointment at Shanghai Institutions of Higher Learning)

  • Zhicheng Zuo

National Science Foundation (MCB-1716423)

  • Rakhi Rajan

National Institute of General Medical Sciences (P20GM103640)

  • Rakhi Rajan

University of North Texas Health Science Center (Start-up Fund and Faculty Pilot Grant)

  • Yu-Chieh Wang

University of North Texas Health Science Center (Start-up Fund and Basic Research Seed Grant)

  • Jin Liu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, Zuo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,526
    views
  • 486
    downloads
  • 26
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Zhicheng Zuo
  2. Ashwini Zolekar
  3. Kesavan Babu
  4. Victor JT Lin
  5. Hamed S Hayatshahi
  6. Rakhi Rajan
  7. Yu-Chieh Wang
  8. Jin Liu
(2019)
Structural and functional insights into the bona fide catalytic state of Streptococcus pyogenes Cas9 HNH nuclease domain
eLife 8:e46500.
https://doi.org/10.7554/eLife.46500

Share this article

https://doi.org/10.7554/eLife.46500

Further reading

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Liza Dahal, Thomas GW Graham ... Xavier Darzacq
    Research Article

    Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Angel D'Oliviera, Xuhang Dai ... Jeffrey S Mugridge
    Research Article

    The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.